Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery Rafael Sanjuán, PhD, Marisa Blasco, PhD, Nieves Carbonell, MD,

Slides:

Advertisements

Similar presentations

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Advertisements

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Reply The Annals of Thoracic Surgery

Late Vascular Complications After Extracorporeal Membrane Oxygenation Support Daniel Zimpfer, MD, Birgit Heinisch, MD, Martin Czerny, MD, Thomas Hoelzenbein,

Outcomes of Reintervention on the Autograft After Ross Procedure

Joshua E. Rosen, BASc, Hari B

Preoperative Serum Soluble Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin Predict Postoperative Atrial Fibrillation in Patients Undergoing.

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer Lars P. Riber, MD, PhD, Thomas D. Christensen,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database James S. Gammie, MD, Michel Haddad, MD,

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

A Randomized Trial Evaluating Amiodarone for Prevention of Atrial Fibrillation After Pulmonary Resection James E. Tisdale, PharmD, Heather A. Wroblewski,

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,

The Impact of Specific Preoperative Organ Dysfunction in Patients Undergoing Aortic Valve Replacement Vinod H. Thourani, MD, Ritam Chowdhury, MD, Rebecca.

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Operative Results and Outcomes in Children With Shone's Anomaly

Mitral commissurotomy, a technique outdated

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Fate of Functional Mitral Regurgitation and Predictors of Persistent Mitral Regurgitation After Isolated Aortic Valve Replacement Hyun-Chel Joo, MD,

Eduardo Crema, PhD, MD, Lara B. P. Ribeiro, Juverson A. Terra, Alex A

Positron Emission Tomography-Computed Tomography for Postoperative Surveillance in Non-Small Cell Lung Cancer Se Hoon Choi, MD, Young Tae Kim, MD, PhD,

Very Long-Term Results of Surgical and Transcatheter Ablation of Long-Standing Persistent Atrial Fibrillation Fiorenzo Gaita, MD, Elisa Ebrille, MD,

Amedeo Anselmi, MD, Gianfederico Possati, MD, Mario Gaudino, MD

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

Intraoperative Radiofrequency Ablation for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery Michael E. Halkos, MD, Joseph M. Craver,

Lung Cancer Surgery in Patients With Liver Cirrhosis

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Observational Study on the Beneficial Effect of Preoperative Statins in Reducing Atrial Fibrillation After Coronary Surgery Giovanni Mariscalco, MD,

Intraoperative Modified Cox Mini-Maze Procedure for Long-Standing Persistent Atrial Fibrillation Yong Qiang Cui, MD, PhD, Ling Bo Sun, MD, PhD, Yan Li,

James D. St. Louis, MD The Annals of Thoracic Surgery

Incidence and Predictors of Aggravation of Mitral Regurgitation After Atrial Septal Defect Closure Shunsuke Nishimura, MD, Chisato Izumi, MD, PhD, Masashi.

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Left-Sided Surgical Ablation for Patients With Atrial Fibrillation Who Are Undergoing Concomitant Cardiac Surgical Procedures Niv Ad, MD, Sari D. Holmes,

Primary Cardiac Sarcoma

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Cardiac Arrhythmia After Open Thoracoabdominal Aortic Aneurysm Repair

Prospective Assessment of the CryoMaze Procedure With Continuous Outpatient Telemetry in 136 Patients A. Claire Watkins, MD, Cindi A. Young, BSN, Mehrdad.

Characteristics of Malignant Pleural Mesothelioma in Women

Editorial Board, January 2010

Superior Transseptal Approach to Mitral Valve Is Associated With a Higher Need for Pacemaker Implantation Than the Left Atrial Approach Peter Lukac,

A. Thomas Pezzella, MD, Sari D

Patrick K. H. O’Brien, MD, John C. Kucharczuk, MD, M

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Left-Sided Reoperations After Arterial Switch Operation: A European Multicenter Study Vladimiro L. Vida, MD, PhD, Lorenza Zanotto, MD, Lucia Zanotto,

Determinants and Prognosis of Myocardial Damage After Coronary Artery Bypass Grafting Francesco Onorati, MD, Marisa De Feo, MD, PhD, Pasquale Mastroroberto,

Long-Term Outcome of Survivors of Prolonged Intensive Care Treatment After Cardiac Surgery Maurizio Mazzoni, MD, Renata De Maria, MD, Franco Bortone,

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

John M. Stulak, MD, Thoralf M. Sundt, MD, Joseph A

The Impact of New Technology on Cardiothoracic Surgical Practice

Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement Heinrich Koertke, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Coronary malperfusion due to type a aortic dissection: mechanism and surgical management Koji Kawahito, MD, Hideo Adachi, MD, Sei-ichiro Murata, MD,

Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients Jeevan Nagendran, MD, PhD, Colleen M. Norris,

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Risk of Valve-Related Events After Aortic Valve Repair

Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,

Hari Padmanabhan, MRCP, Matthew J. Brookes, PhD, Alan M

Kim I. de la Cruz, MD, Faisal G

Presentation transcript:

Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery Rafael Sanjuán, PhD, Marisa Blasco, PhD, Nieves Carbonell, MD, Angela Jordá, MD, Julio Núñez, MD, Juan Martínez-León, PhD, Eduardo Otero, PhD The Annals of Thoracic Surgery Volume 77, Issue 3, Pages 838-843 (March 2004) DOI: 10.1016/j.athoracsur.2003.06.014

Fig 1 Kaplan-Meier curve illustrating the cumulative percentage of patients free of atrial fibrillation at follow-up, stratified by treatment group. Thin line = atenolol; thick line = sotalol. The Annals of Thoracic Surgery 2004 77, 838-843DOI: (10.1016/j.athoracsur.2003.06.014)

Fig 2 Distribution of atrial fibrillation occurrence by treatment group. = atenolol; ■ = sotalol. The Annals of Thoracic Surgery 2004 77, 838-843DOI: (10.1016/j.athoracsur.2003.06.014)